Almhana, Farah http://orcid.org/0000-0002-5129-1894
Mital, Rohan
Chung, Catherine G.
Korman, Abraham M.
Kaffenberger, Benjamin H.
Article History
Received: 6 May 2023
Revised: 6 May 2023
Accepted: 17 May 2023
First Online: 10 June 2023
Declarations
:
: B.H. Kaffenberger receives research funding from Biogen, BMS, InflaRx, onQuality, Cara Pharmaceuticals, Dermatology Foundation, and the National Psoriasis Foundation, honoraria from Elsevier, is a consultant for ADC Therapeutics, Biogen, Eli Lilly, Novartis, and Novacure, and is a member of the NCCN panel for Immunotherapy.